Purinergic signaling in infection and autoimmune disease
Luiz Eduardo Baggio Savio, Robson Coutinho-Silva
Biomedical Journal · 2016
doi:10.1016/j.bj.2016.09.002 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Purinergic signaling plays a key role in inflammatory processes and modulates immune responses against a variety of bacterial and eukaryotic parasites. Here we highlight the role of purinergic receptor activation in infection and autoimmune diseases. Purinergic signaling and inflammasomes modulate the host immune response against chlamydial infections. In addition, increasing evidence suggests that purinergic signaling contributes to Schistosomiasis morbidity, a neglected tropical disease caused by parasitic worms called schistosomes. Finally, the P2X7 receptor and NLRP3 inflammasome have been described to be involved in the pathogenesis of systemic lupus erythematosus, suggesting that these signaling pathways as suitable therapeutic targets for management and treatment of different immune diseases. Keywords: Purinergic receptors, Schistosoma mansoni, NLRP3 inflammasome, P2X7 receptor, Chlamydia, Systemic lupus erythematosus
Abstract licence: CC BY-NC-ND
References19
- 6.
18 more references, whose wording the paper’s licence keeps private.
Cited by papers we hold2
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.